Business · 07/09/2007
FDA Releases Guidance for Manufacturing Biological Intermediates and Biological Drug Substances Using Spore-Forming Microorganisms
The FDA has released a guidance document providing recommendations to manufacturers of biological products using spore-forming microorganisms, following changes to the requirements for these microorganisms.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →